Conferences
ESMO 2017: DNA repair gene panel mutations in young onset and aggressive v non-aggressive prostate cancer cases in the UK
September 10, 2017
ESMO 2017: Ramucirumab plus docetaxel improves progression-free survival in urothelial cancer
September 10, 2017
ESMO 2017: Mature results favour pembrolizumab as second-line treatment for bladder cancer
September 10, 2017
ESMO 2017: Panel Discussion – Targeted Alpha Therapy
September 9, 2017
ESMO 2017: The Future of Targeted Alpha Therapy
September 9, 2017
ESMO 2017: The Evolving Landscape of Treating Advanced Prostate Cancer
September 9, 2017
ESMO 2017: Benefits of Abiraterone Acetate Plus Prednisone When Added to Androgen Deprivation Therapy in LATITUDE on Patient Reported Outcomes
September 9, 2017
ESMO 2017: Patients with High Risk Prostate Cancer May Benefit “Equally” From Two New Treatments
September 9, 2017
ASCO 2017: Identifying and Targeting Genetic Drivers in Rare Genitourinary Cancer Types
July 8, 2017